:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1970763277-c36cdc0c672243b8a5a512edcdb8ee27.jpg)
In March 2025, the U.S. imported more pharmaceutical preparations than any other product, totaling $50.4 billion. This was an increase of 71% from February 2025, largely due to Trump’s tariffs.
The largest import category was consumer goods at $103.2 billion, of which pharmaceutical preparations fall under.
Key Takeaways
- The U.S.’s top import is pharmaceutical preparations, which surged in March 2025 due largely to companies stockpiling in the face of possible new tariffs by the Trump administration.
- A large portion of the United States’ medicines come from countries like Ireland and Germany, showing just how dependent the U.S. is on foreign-made drugs.
- The U.S. needs a steady stream of medications to keep up with the high demand driven by chronic illnesses, an aging population, and an expensive healthcare system.
Pharmaceutical Preparations Imports
Pharmaceutical preparations, which includes medications, vaccines, and health-related products, may not have been the first guess for the largest U.S. import; however, it has been at the top of the list for some time.
A significant portion of the U.S. drug supply comes from countries with advanced pharmaceutical manufacturing industries, such as Ireland, Germany, and Switzerland. In March 2025, Ireland alone accounted for $28 billion of pharmaceutical imports, showing the reliance on foreign production.
In addition, the U.S. has a high demand for both generic and branded medications, many of which are produced abroad. The high demand is a result of its aging population (by 2030, one in five Americans will be 65 or older), the prevalence of chronic diseases, and the country’s relatively high healthcare costs.
Another factor is the complex and global nature of the pharmaceutical supply chain. Drug companies may source raw materials from one country, while the final product may be manufactured and packaged in another.
This interconnected system ensures that pharma products can move easily between countries, making the U.S. one of the largest importers in the world.
Surge in Imports
The large surge in pharmaceutical preparations imports in 2025 was due to companies accelerating imports in anticipation of potential tariffs imposed by the Trump administration.
Trump’s goal with the tariffs is to encourage domestic manufacturing, which has decreased due to lower labor costs abroad and other countries picking up the skill set needed to create such products.
The uncertainty of the tariffs led many companies to stockpile drugs and raw materials to mitigate the high cost should the tariffs go into effect. While no tariffs went into effect in March 2025, the threat still looms.
Other Top Imports
After consumer goods being the largest U.S. import category, the other largest categories include capital goods, except automotive ($93.1 billion) and industrial supplies and materials ($75.5 billion).
After pharmaceutical preparations, specific category items include finished metal shapes ($21.3 billion), passenger cars ($19.2 billion), and computers ($13.6 billion).
Top Exports
The largest export categories for the U.S. include industrial supplies and materials ($64.6 billion) and capital goods, except automotive ($57.8 billion). The largest specific category items include pharmaceutical preparations ($9.2 billion), crude oil ($9.1 billion), and civilian aircraft engines ($6.3 billion).
The Bottom Line
Pharmaceutical preparations, already the top U.S. import, surged in March 2025 as companies rushed to stock up ahead of potential Trump-era tariffs. With much of the supply coming from countries like Ireland, the increase underscores the U.S.’s heavy reliance on global pharmaceutical manufacturing.
